Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$65.8M |
| 2 |
Las Vegas Sands
LVS
|
+$61.9M |
| 3 |
Consolidated Edison
ED
|
+$42.4M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$39.1M |
| 5 |
CMS Energy
CMS
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$68.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$41.1M |
| 3 |
Pinnacle West Capital
PNW
|
+$25.6M |
| 4 |
Eversource Energy
ES
|
+$23.6M |
| 5 |
FirstEnergy
FE
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 15.61% |
| 2 | Technology | 12.98% |
| 3 | Industrials | 12.91% |
| 4 | Consumer Discretionary | 9.54% |
| 5 | Financials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNL
526
DELISTED
Knoll, Inc.
KNL
| $676K | 0.02% |
+26,654
| New | +$632K |
|
527
Manulife Financial
MFC
$70.8B
| $675K | 0.02% |
36,760
-6,526
| -15% | -$115K |
|
528
Equinor
EQNR
$101B
| $674K | 0.02% |
+35,581
| New | +$655K |
|
|
BMCH
529
DELISTED
BMC Stock Holdings, Inc
BMCH
| $672K | 0.02% |
25,664
+2,205
| +9% | +$52.5K |
|
530
Travelers Companies
TRV
$77.3B
| $671K | 0.02% |
+4,516
| New | +$671K |
|
531
iShares MSCI Singapore ETF
EWS
$1.23B
| $670K | 0.02% |
+28,900
| New | +$684K |
|
532
EPR Properties
EPR
$4.64B
| $669K | 0.02% |
8,700
+2,800
| +47% | +$213K |
|
533
Gentex
GNTX
$4.96B
| $669K | 0.02% |
24,313
+8,112
| +50% | +$214K |
|
534
Allison Transmission
ALSN
$10.9B
| $668K | 0.02% |
+14,198
| New | +$644K |
|
535
ResMed
RMD
$33.5B
| $664K | 0.02% |
+4,916
| New | +$644K |
|
536
Sunstone Hotel Investors
SHO
$2.1B
| $664K | 0.02% |
48,329
+19,976
| +70% | +$268K |
|
537
NovoCure
NVCR
$1.96B
| $662K | 0.02% |
+8,857
| New | +$708K |
|
|
SHOE
538
Shoe Station Group
SHOE
$424M
| $660K | 0.02% |
40,726
+22,400
| +122% | +$311K |
|
539
Constellium
CSTM
$3.58B
| $658K | 0.02% |
+51,762
| New | +$609K |
|
540
Navient
NAVI
$875M
| $658K | 0.02% |
51,443
+38,806
| +307% | +$517K |
|
541
Universal Health Services
UHS
$10.4B
| $657K | 0.02% |
+4,416
| New | +$634K |
|
542
Resideo Technologies
REZI
$3B
| $656K | 0.02% |
+45,700
| New | +$766K |
|
|
ACC
543
DELISTED
American Campus Communities, Inc.
ACC
| $655K | 0.02% |
+13,618
| New | +$643K |
|
544
Molina Healthcare
MOH
$10.4B
| $651K | 0.02% |
5,931
+988
| +20% | +$128K |
|
|
NSA
545
DELISTED
National Storage Affiliates Trust
NSA
| $650K | 0.02% |
19,481
+4,295
| +28% | +$136K |
|
|
RDUS
546
DELISTED
Radius Health, Inc.
RDUS
| $650K | 0.02% |
+25,240
| New | +$619K |
|
547
Carpenter Technology
CRS
$23.5B
| $646K | 0.02% |
12,500
+7,900
| +172% | +$382K |
|
548
News Corp Class A
NWSA
$16.6B
| $646K | 0.02% |
+46,388
| New | +$634K |
|
549
Tenet Healthcare
THC
$22.4B
| $646K | 0.02% |
29,200
-6,462
| -18% | -$138K |
|
550
Verisk Analytics
VRSK
$24.7B
| $646K | 0.02% |
4,084
-600
| -13% | -$93.1K |
|
Similar funds
Michael Gelband's Q3 2019 Portfolio in Review
As of Q3 2019, Michael Gelband held 1,809 positions worth $2.86B, up 14% from $2.51B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Michael Gelband deployed $315M of net new capital in Q3 2019, opening 745 new positions and adding to 318 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
By sector, the portfolio is most concentrated in Utilities at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $41.1M trimmed.
- Michael Gelband's largest Q3 2019 buy was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
- Michael Gelband added most to Aramark in Q3 2019, an estimated $65.8M increase.
- Michael Gelband's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $41.1M.
- Michael Gelband fully exited Altaba Inc in Q3 2019, selling an estimated $68.3M.
- Michael Gelband's ten largest holdings make up 24% of its $2.86B portfolio in Q3 2019.
- Michael Gelband opened 745 new positions and closed 516 in Q3 2019.
- Michael Gelband's portfolio value rose 14% quarter-over-quarter to $2.86B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.